|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
6/13/2013
|
Balo Andrew K
|
SVP, Regulatory and Clinical
|
10,000
|
$2.40
|
6.92%
|
|
6/13/2013
|
Balo Andrew K
|
SVP, Regulatory and Clinical
|
-10,000
|
$21.90
|
-6.47%
|
|
6/11/2013
|
ROPER JESS
|
VP, CFO
|
-10,361
|
$22.33
|
-12.69%
|
|
6/11/2013
|
LISTER JOHN
|
General Counsel, VP of HR
|
-2,000
|
$22.43
|
-2.51%
|
|
6/11/2013
|
Pacelli Steven Robert
|
EVP, Strategy & Corp. Dev.
|
-5,000
|
$22.31
|
-2.34%
|
|
6/10/2013
|
VALDES JORGE A
|
CTO
|
-1,992
|
$22.03
|
-1.08%
|
|
6/10/2013
|
Pacelli Steven Robert
|
EVP, Strategy & Corp. Dev.
|
-2,765
|
$22.03
|
-1.28%
|
|
6/4/2013
|
GREGG TERRANCE H
|
CEO
|
-10,000
|
$21.80
|
-1.25%
|
|
6/3/2013
|
GREGG TERRANCE H
|
CEO
|
-9,000
|
$20.79
|
-1.12%
|
|
5/31/2013
|
DOUBLEDAY RICHARD
|
SVP, Worldwide Sales
|
15,000
|
$0.00
|
16.31%
|
|
5/31/2013
|
TOPOL ERIC
|
Director
|
12,207
|
$0.00
|
28.92%
|
|
5/31/2013
|
SKYLER JAY S
|
Director
|
11,848
|
$0.00
|
9.71%
|
|
5/31/2013
|
LORD JONATHAN T MD
|
Director
|
15,079
|
$0.00
|
13.32%
|
|
5/31/2013
|
KAHN BARBARA
|
Director
|
11,130
|
$0.00
|
28.08%
|
|
5/31/2013
|
AUGUSTINOS NICHOLAS
|
Director
|
11,130
|
$0.00
|
28.19%
|
|
5/15/2013
|
MOY JEFFREY
|
SVP, Operations
|
-5,000
|
$19.98
|
-2.51%
|
|
5/15/2013
|
MOY JEFFREY
|
SVP, Operations
|
5,000
|
$3.19
|
2.57%
|
|
5/13/2013
|
Balo Andrew K
|
SVP, Regulatory and Clinical
|
-45,000
|
$19.40
|
-23.74%
|
|
5/13/2013
|
Balo Andrew K
|
SVP, Regulatory and Clinical
|
45,000
|
$2.40
|
31.13%
|
|
5/9/2013
|
DOUBLEDAY RICHARD
|
SVP, Worldwide Sales
|
-580
|
$19.56
|
-0.63%
|
|
5/9/2013
|
DOUBLEDAY RICHARD
|
SVP, Worldwide Sales
|
-692
|
$19.55
|
-0.74%
|
|
5/1/2013
|
GREGG TERRANCE H
|
CEO
|
-9,000
|
$16.84
|
-1.10%
|
|
4/1/2013
|
GREGG TERRANCE H
|
CEO
|
-9,000
|
$16.90
|
-1.09%
|
|
3/13/2013
|
Pacelli Steven Robert
|
EVP, Strategy & Corp. Dev.
|
-21,395
|
$15.69
|
-9.00%
|
|
3/13/2013
|
Balo Andrew K
|
SVP, Regulatory and Clinical
|
-15,416
|
$16.53
|
-9.64%
|
|
3/13/2013
|
Balo Andrew K
|
SVP, Regulatory and Clinical
|
15,416
|
$0.50
|
10.66%
|
|
3/13/2013
|
Balo Andrew K
|
SVP, Regulatory and Clinical
|
-9,647
|
$15.69
|
-6.26%
|
|
3/13/2013
|
DOUBLEDAY RICHARD
|
SVP, Worldwide Sales
|
-4,067
|
$15.69
|
-4.18%
|
|
3/13/2013
|
SAYER KEVIN R
|
President & COO
|
-15,901
|
$15.69
|
-4.25%
|
|
3/13/2013
|
MOY JEFFREY
|
SVP, Operations
|
-10,423
|
$15.69
|
-5.09%
|
|
3/13/2013
|
ROPER JESS
|
VP, CFO
|
-5,001
|
$15.69
|
-5.77%
|
|
3/13/2013
|
VALDES JORGE A
|
CTO
|
-15,655
|
$15.69
|
-7.79%
|
|
3/13/2013
|
LISTER JOHN
|
VP of Legal Affairs
|
-5,947
|
$15.69
|
-6.94%
|
|
3/12/2013
|
VALDES JORGE A
|
CTO
|
-21,054
|
$16.31
|
-9.49%
|
|
3/11/2013
|
Balo Andrew K
|
SVP, Regulatory and Clinical
|
50,000
|
$0.00
|
47.98%
|
|
3/11/2013
|
SKYLER JAY S
|
Director
|
70,000
|
$15.50
|
134.68%
|
|
3/11/2013
|
GREGG TERRANCE H
|
CEO
|
182,813
|
$0.00
|
609.38%
|
|
3/11/2013
|
VALDES JORGE A
|
CTO
|
-2,000
|
$15.58
|
-1.31%
|
|
3/11/2013
|
LISTER JOHN
|
VP of Legal Affairs
|
35,000
|
$0.00
|
63.39%
|
|
3/11/2013
|
VALDES JORGE A
|
CTO
|
71,621
|
$0.00
|
47.64%
|
|
3/11/2013
|
Pacelli Steven Robert
|
EVP, Strategy & Corp. Dev.
|
71,621
|
$0.00
|
43.13%
|
|
3/11/2013
|
SAYER KEVIN R
|
President & COO
|
150,000
|
$0.00
|
66.88%
|
|
3/11/2013
|
LISTER JOHN
|
VP of Legal Affairs
|
-4,500
|
$15.75
|
-4.99%
|
|
3/11/2013
|
ROPER JESS
|
VP, CFO
|
30,000
|
$0.00
|
52.95%
|
|
3/11/2013
|
MOY JEFFREY
|
SVP, Operations
|
50,000
|
$0.00
|
32.33%
|
|
3/11/2013
|
DOUBLEDAY RICHARD
|
SVP, Worldwide Sales
|
50,000
|
$0.00
|
95.40%
|
|
3/11/2013
|
DOUBLEDAY RICHARD
|
SVP, Worldwide Sales
|
-5,100
|
$15.63
|
-4.98%
|
|
3/8/2013
|
VALDES JORGE A
|
CTO
|
-1,000
|
$15.61
|
-0.65%
|
|
3/1/2013
|
GREGG TERRANCE H
|
CEO
|
-9,000
|
$14.76
|
-1.08%
|
|
2/28/2013
|
Pacelli Steven Robert
|
EVP, Strategy & Corp. Dev.
|
-25,000
|
$14.99
|
-13.09%
|
|
2/28/2013
|
Pacelli Steven Robert
|
EVP, Strategy & Corp. Dev.
|
25,000
|
$3.19
|
15.06%
|
|
2/27/2013
|
Pacelli Steven Robert
|
EVP, Strategy & Corp. Dev.
|
-20,000
|
$15.01
|
-10.75%
|
|
2/27/2013
|
Pacelli Steven Robert
|
EVP, Strategy & Corp. Dev.
|
20,000
|
$3.19
|
12.04%
|
|
2/26/2013
|
Pacelli Steven Robert
|
EVP, Strategy & Corp. Dev.
|
30,000
|
$3.19
|
18.07%
|
|
2/26/2013
|
Pacelli Steven Robert
|
EVP, Strategy & Corp. Dev.
|
-30,000
|
$14.95
|
-15.30%
|
|
2/1/2013
|
GREGG TERRANCE H
|
CEO
|
-9,000
|
$15.08
|
-1.07%
|
|
1/2/2013
|
GREGG TERRANCE H
|
CEO
|
-9,000
|
$13.89
|
-1.06%
|
|
12/13/2012
|
VALDES JORGE A
|
CTO
|
-22,939
|
$14.00
|
-100.00%
|
|
12/13/2012
|
VALDES JORGE A
|
CTO
|
-4,811
|
$14.10
|
-17.34%
|
|
12/13/2012
|
Balo Andrew K
|
SVP, Regulatory and Clinical
|
-5,760
|
$13.98
|
-5.25%
|
|
12/13/2012
|
Balo Andrew K
|
SVP, Regulatory and Clinical
|
-7,000
|
$13.96
|
-100.00%
|
|
12/12/2012
|
VALDES JORGE A
|
CTO
|
-4,122
|
$14.29
|
-12.93%
|
|
12/11/2012
|
Pacelli Steven Robert
|
EVP, Strategy & Corp. Dev.
|
10,000
|
$3.19
|
6.02%
|
|
12/11/2012
|
Pacelli Steven Robert
|
EVP, Strategy & Corp. Dev.
|
-10,000
|
$14.27
|
-5.68%
|
|
12/10/2012
|
ROPER JESS
|
VP, CFO
|
-714
|
$13.83
|
-1.20%
|
|
12/10/2012
|
ROPER JESS
|
VP, CFO
|
-5,000
|
$13.85
|
-100.00%
|
|
12/10/2012
|
ROPER JESS
|
VP, CFO
|
-3,001
|
$13.84
|
-5.11%
|
|
12/3/2012
|
SAYER KEVIN R
|
President
|
-6,110
|
$13.01
|
-2.65%
|
|
12/3/2012
|
GREGG TERRANCE H
|
CEO
|
-5,000
|
$13.24
|
-0.54%
|
|
11/5/2012
|
GREGG TERRANCE H
|
CEO
|
-5,000
|
$12.76
|
-0.53%
|
|
10/3/2012
|
GREGG TERRANCE H
|
CEO
|
-5,000
|
$14.93
|
-0.53%
|
|
9/14/2012
|
GREGG TERRANCE H
|
CEO
|
-9,000
|
$13.50
|
-0.95%
|
|
9/10/2012
|
VALDES JORGE A
|
CTO
|
-6,417
|
$13.68
|
-4.02%
|
|
9/10/2012
|
Balo Andrew K
|
SVP, Regulatory and Clinical
|
-2,734
|
$13.68
|
-2.43%
|
|
9/10/2012
|
LISTER JOHN
|
VP of Legal Affairs
|
-1,602
|
$13.68
|
-2.82%
|
|
9/10/2012
|
DOUBLEDAY RICHARD
|
VP of Sales
|
-1,302
|
$13.68
|
-2.47%
|
|
9/10/2012
|
MOY JEFFREY
|
SVP, Operations
|
-4,687
|
$13.68
|
-2.98%
|
|
9/10/2012
|
Pacelli Steven Robert
|
EVP, Strategy & Corp. Dev.
|
-6,417
|
$13.68
|
-3.72%
|
|
9/10/2012
|
ROPER JESS
|
VP, CFO
|
-1,602
|
$13.68
|
-2.62%
|
|
9/4/2012
|
GREGG TERRANCE H
|
CEO
|
-15,000
|
$13.46
|
-1.55%
|
|
8/31/2012
|
MOY JEFFREY
|
SVP, Operations
|
-10,000
|
$13.30
|
-5.98%
|
|
8/15/2012
|
MOY JEFFREY
|
SVP, Operations
|
-21,249
|
$12.80
|
-11.27%
|
|
8/3/2012
|
GREGG TERRANCE H
|
CEO
|
-5,000
|
$11.60
|
-0.52%
|
|
7/3/2012
|
GREGG TERRANCE H
|
CEO
|
-5,000
|
$13.03
|
-0.51%
|
|
6/4/2012
|
GREGG TERRANCE H
|
CEO
|
-5,000
|
$10.78
|
-0.51%
|
|
6/4/2012
|
SAYER KEVIN R
|
President
|
-12,077
|
$10.68
|
-4.98%
|
|
6/1/2012
|
AUGUSTINOS NICHOLAS
|
Director
|
17,992
|
$0.00
|
83.74%
|
|
6/1/2012
|
LORD JONATHAN T MD
|
Director
|
24,376
|
$0.00
|
27.43%
|
|
6/1/2012
|
KAHN BARBARA
|
Director
|
17,992
|
$0.00
|
83.14%
|
|
6/1/2012
|
SKYLER JAY S
|
Director
|
19,153
|
$0.00
|
58.35%
|
|
6/1/2012
|
DOORDAN MARTIN
|
Director
|
17,992
|
$0.00
|
83.14%
|
|
6/1/2012
|
TOPOL ERIC
|
Director
|
19,733
|
$0.00
|
87.82%
|
|
5/18/2012
|
Balo Andrew K
|
SVP, Regulatory and Clinical
|
-14,198
|
$10.46
|
-11.22%
|
|
5/18/2012
|
Balo Andrew K
|
SVP, Regulatory and Clinical
|
28,466
|
$0.50
|
29.04%
|
|
5/3/2012
|
GREGG TERRANCE H
|
CEO
|
-5,000
|
$9.95
|
-0.51%
|
|
4/3/2012
|
GREGG TERRANCE H
|
CEO
|
-5,000
|
$10.64
|
-0.51%
|
|
3/8/2012
|
MOY JEFFREY
|
SVP, Operations
|
-3,833
|
$10.26
|
-1.99%
|
|
3/8/2012
|
MOY JEFFREY
|
SVP, Operations
|
-5,615
|
$10.26
|
-2.84%
|
|
3/8/2012
|
MOY JEFFREY
|
SVP, Operations
|
43,750
|
$0.00
|
28.37%
|
|
3/8/2012
|
SAYER KEVIN R
|
President
|
125,000
|
$0.00
|
106.42%
|